Corbus Pharmaceuticals Holdings (CRBP) Current Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• On a quarterly basis, Current Leases rose 1.68% year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $1.6 million, a 1.68% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 1.68% from the prior year.
• Current Leases slipped to $1.6 million in Q4 2025 per CRBP's latest filing, from $1.7 million in the prior quarter.
• Across five years, Current Leases topped out at $1.7 million in Q3 2025 and bottomed at $1.0 million in Q1 2021.
• The 5-year median for Current Leases is $1.4 million (2023), against an average of $1.4 million.
• Across the five-year window, Current Leases surged 39.49% in 2021 and rose 1.68% in 2025, its largest moves.
• Year by year, Current Leases stood at $1.1 million in 2021, then increased by 12.66% to $1.3 million in 2022, then grew by 12.19% to $1.4 million in 2023, then grew by 11.76% to $1.6 million in 2024, then rose by 1.68% to $1.6 million in 2025.
• Per Business Quant, the three latest CRBP Current Leases figures stand at $1.6 million (Q4 2025), $1.7 million (Q3 2025), and $1.7 million (Q2 2025).